News and Announcements
Actinogen has US Patent Granted and Further Extends Xanamem Protection
- Published July 21, 2016 3:26PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
20th July 2016, ASX Announcement
- United States Patent granted for use of Xanamem™ in Alzheimer’s dementia and other diseases.
- Xanamem™’s long patent life now further extended to 2031 in the US.
- Comprehensive protection over Xanamem™ now received for most major markets.
Actinogen Medical Limited (Actinogen Medical, ASX: ACW), is pleased to announce it has received official notification to grant from the United States Patent Office for the most comprehensive patent for Xanamem. This patent further extends the comprehensive cover for Xanamem through to 2031.
The patent ( US 9,365,654 B2) protects use of Xanamem™ for use in Alzheimer’s dementia and other relate diseases associated with the inhibition of the 11-beta-hydroxysteroid dehydrogenase (11β-HSD1) enzyme. Importantly this patent cover through to 2031 comes on top of previous approvals in most other major markets, including all European countries and the UK, Australia, Japan and China.
To view the full announcement, please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
